• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  03/29/2006
Trade Name:  Relenza
Generic Name or Proper Name (*):  zanamivir
Indications Studied:  Prevention of influenza in children 5 years of age and older
Label Changes Summary:  * Safety and effectiveness for prophylaxis based on 4 clinical studies in patients 5-16 years of age * No differences in safety and effectiveness were observed between pediatric and adult subjects. * Dosing information provided * Studies waived in children <5 years of age * New indication
Product Labeling:  Labeling  Opens a new window
Sponsor:  GlaxoSmithKline
Therapeutic Category:  Antiviral